CDC
CDC (CDC) is a company in Vietnam's Construction & Materials sector, listed on HOSE. The stock last traded at 19,250 VND, little changed on the session, giving a market capitalization of 2.0 trillion VND.
On valuation, CDC trades at a price-to-earnings ratio of 133.3 and a price-to-book of 2.4. That is a premium to the Construction & Materials sector average P/E of 20.8. Return on equity of 1.8% points to weak profitability relative to the company's equity base, below the sector average of 8.2%. Trailing earnings per share stand at 140 VND.
Aveluro tracks 4 news items mentioning CDC, where recent coverage skews mixed (50% of articles). The most recent catalyst was a capital raise event — "CDC Plans to Sell 32.34% Stake in Subsidiary, Extends Rights Offering". Aveluro's composite model rates CDC 5.5/10 (Neutral), blending news sentiment, price momentum, and fundamentals.
Comparable names in the Construction & Materials sector include ACC, ACE and ACS.
CDC Plans to Sell 32.34% Stake in Subsidiary, Extends Rights Offering
Recent developments around CDC include 2 notable classified events. On Apr 30, 2026, a market event was reported: CDC plans to sell 32.34% of its subsidiary Chuong Duong Homeland for at least VND 190 billion, reducing its stake from 59.7% to 27.27%. On Apr 15, 2026, a market event was reported: MSN was the top net buy by securities company proprietary trading desks on April 15, with VND 38 billion in purchases, while foreign investors sold a net VND 3,651 billion across the HoSE.
Recent coverage shows a mixed sentiment balance across events.
By Aveluro Research Team · Editorial policy · Caveat: Not investment advice. · How Aveluro computed this